InvestorsHub on MSN
Brainsway Shares Jump After FDA Extends Deep TMS Approval to Teen Depression
Brainsway Ltd. (NASDAQ:BWAY) saw its stock pop 5% in premarket trading Thursday after securing a key FDA label expansion for its Deep Transcranial Magnetic Stimulation (Deep TMS) system, clearing the ...
BrainsWay (BWAY) announced recent positive pilot data from an independent, third-party study conducted at Stanford University evaluating an accelerated protocol using the Company’s Deep Transcranial ...
BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Credit: BrainsWay. The outpatient procedure provides noninvasive magnetic stimulation through a cushioned helmet to induce electrical currents in localized regions of the prefrontal cortex. Real-world ...
NEW YORK, March 13, 2026 /PRNewswire/ -- Radial today announced publication of a landmark study showing accelerated Deep TMS can treat depression in six days instead of months. The research evaluated ...
Moment of Clarity has published a new educational resource titled “How Deep TMS Therapy Works,” providing a comprehensive overview of transcranial magnetic stimulation (TMS) and its emerging role in ...
BURLINGTON, Mass. and JERUSALEM, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results